A cardinal feature of malignant melanoma is its metastatic propensity. An incomplete view of the genetic events driving metastatic progression has been a major barrier to rational development of effective therapeutics and prognostic diagnostics for melanoma patients. In this study. we conducted global genomic characterization of primary and metastatic melanomas to examine the genomic ... https://www.roneverhart.com/Aftermath-Cabernet-Sauvignon-Napa-Valley-2017/